Skip to main content
Axios Logo
Newsletters
Axios Local
Show
Axios Pro
Axios Live
The Axios Show
Login
Deals Logo
All deals
Deals Logo
Subscribe
Axios Logo
Newsletters
Axios Local
Show
Axios Pro
Axios Live
The Axios Show
Login
Deals Logo
All deals
Deals Logo
Subscribe
Axios Pro Exclusive Content
Biotech deals of the week
Katherine Davis
12 hours ago
email (opens in new window)
sms (opens in new window)
facebook (opens in new window)
twitter (opens in new window)
linkedin (opens in new window)
bluesky (opens in new window)
Illustration: Aïda Amer/Axios
Exit Content Preview
Venture Capital
Delix Therapeutics
, a Bedford, Mass.-based psychedelic pharma company, raised $100m in Series C funding led by
Johnson & Johnson
. It had previously announced $85m of the round.
Go deeper
email (opens in new window)
sms (opens in new window)
facebook (opens in new window)
twitter (opens in new window)
linkedin (opens in new window)
bluesky (opens in new window)
What to read next